Quercetin liposome sensitizes colon carcinoma to thermotherapy and thermochemotherapy in mice models

Integrative Cancer Therapies

Volumn 12, Issue 3, 2013, Pages 264-270

  He, Bing ^a   Wang, Xin ^a   Shi, Hua Shan ^a   Xiao, Wen Jing ^a   Zhang, Jing ^a   Mu, Bo ^a   Mao, Yong Qiu ^a   Wang, Wei ^a   Wang, Yong Sheng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

5 fluorouracil; colon cancer; hyperthermia; quercetin liposome; thermochemotherapy

Indexed keywords

FLUOROURACIL; HEAT SHOCK PROTEIN 70; LIPOSOME; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CARCINOMATOUS PERITONITIS; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HYPERTHERMIC THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; THERMOCHEMOTHERAPY; TUMOR CELL; UPREGULATION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DOWN-REGULATION; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; LIPOSOMES; MICE; MICE, INBRED BALB C; QUERCETIN; UP-REGULATION;

EID: 84876584188     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735412446863     Document Type: Article

References (31)

1. Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002 ; 3: 487-497
2. Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002 ; 43: 33-56
3. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst. 2000 ; 92: 1564-1572
4. Isomoto H, Oka M, Yano Y, et al. Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer. Cancer Lett. 2003 ; 198: 219-228
5. Rashmi R, Kumar S, Karunagaran D. Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis ; 2004 ; 2004. 179.
6. Choi JA, Kim JY, Lee JY, et al. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol. 2001 ; 19: 837-844
7. Kuo SM. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 1996 ; 110: 41-48
8. Ong CS, Tran E, Nguyen TT, et al. Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncol Rep. 2004 ; 11: 727-733
9. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 1994 ; 54: 4952-4957
10. Ye B, Yang JL, Chen LJ, et al. Induction of apoptosis by phenylisocyanate derivative of quercetin: involvement of heat shock protein. Anticancer Drugs. 2007 ; 18: 1165-1171
11. Scambia G, Ranelletti FO, Panici PB, et al. Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines. Int J Cancer. 1993 ; 5: 462-466
12. Verma AK, Johnson JA, Gould MN, Tanner MA. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 1988 ; 48: 5754-5758
13. Hosokawa N, Hirayoshi K, Kudo H, et al. Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol Cell Biol. 1992 ; 12: 3490-3498
14. Hosokawa N, Hirayoshi K, Nakai A, et al. Flavonoids inhibit the expression of heat shock proteins. Cell Struct Funct. 1990 ; 15: 393-401
15. Koishi M, Hosokawa N, Sato M, et al. Quercetin, an inhibitor of heat shock protein synthesis, inhibits the acquisition of thermotolerance in a human colon carcinoma cell line. Jpn J Cancer Res. 1992 ; 83: 1216-1222
16. Malyshev I, Bayda LA, Trifonov AI, et al. Cross-talk between nitric oxide and HSP70 in the antihypotensive effect of adaptation to heat. Physiol Res. 2000 ; 49: 99-105
17. Yuan ZQ, Peng YZ, Li XL, Huang YS, Yang ZC. Induction of heat shock protein 70 by sodium arsenite attenuates burn-induced intestinal injury in severe burned rats. Burns. 2008 ; 34: 247-253
18. Yuan ZP, Chen LJ, Fan LY, et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res. 2006 ; 12: 3193-3199
19. Chen T, Guo J, Han C, Yang M, Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol. 2009 ; 182: 1449-1459
20. Ling YH, Priebe W, Perez-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res. 1993 ; 53: 1845-1852
21. Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ. Adjuvant treatment of colorectal cancer. CA Cancer J Clin. 2007 ; 57: 168-185
22. Calderwood SK, Asea A. Targeting HSP70-induced thermotolerance for design of thermal sensitizers. Int J Hyperthermia. 2002 ; 18: 597-608
23. Cui X, Yu ZY, Wang W, Zheng YQ, Liu W, Li LX. Co-inhibition of HSP70/HSP90 synergistically sensitizes nasopharyngeal carcinoma cells to thermotherapy. Integr Cancer Ther. 2011 ;:
24. Zylicz M, King FW, Wawrzynow A. Hsp70 interactions with the p53 tumour suppressor protein. EMBO J. 2001 ; 20: 4634-4638
25. Beebe TJ, Johnson CD, Stoner SM, Anderson KJ, Limburg PJ. Assessing attitudes toward laxative preparation in colorectal cancer screening and effects on future testing: potential receptivity to computed tomographic colonography. Mayo Clin Proc. 2007 ; 82: 666-671
26. Rex DK. Colonoscopy: the dominant and preferred colorectal cancer screening strategy in the United States. Mayo Clin Proc. 2007 ; 82: 662-664
27. Gill S, Blackstock AW, Goldberg RM. Colorectal cancer. Mayo Clin Proc. 2007 ; 82: 114-129
28. Grivicich I, Regner A, Zanoni C, et al. Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines. Int J Colorectal Dis. 2007 ; 22: 1201-1208
29. Kecmanovic DM, Pavlov MJ, Ceranic MS, Sepetkovski AV, Kovacevic PA, Stamenkovic AB. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. Eur J Surg Oncol. 2005 ; 31: 147-152
30. Elias D, Bonnay M, Puizillou JM, et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol. 2002 ; 13: 267-272
31. Flessner MF. The transport barrier in intraperitoneal therapy. Am J Physiol Renal Physiol. 2005 ; 288: F433 - F442